- $306.02bn
- $367.64bn
- $56.33bn
- 94
- 32
- 86
- 82
Annual balance sheet for Abbvie, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 8,479 | 9,830 | 9,229 | 12,816 | 5,555 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8,822 | 9,977 | 11,254 | 11,155 | 10,919 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 24,173 | 27,928 | 28,463 | 33,002 | 25,582 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6,143 | 5,872 | 5,672 | 5,733 | 5,857 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 150,565 | 146,529 | 138,805 | 134,711 | 135,161 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 28,661 | 35,194 | 29,538 | 37,841 | 38,749 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 137,489 | 131,121 | 121,551 | 124,351 | 131,836 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 13,076 | 15,408 | 17,254 | 10,360 | 3,325 |
Total Liabilities & Shareholders' Equity | 150,565 | 146,529 | 138,805 | 134,711 | 135,161 |
Total Common Shares Outstanding |